Showing 1 - 3 results of 3 for search 'Filip Janku', query time: 0.02s Refine Results
  1. 1
    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study

    Efficacy of pembrolizumab in patients with pituitary carcinoma: report of four cases from a phase II study by Siqing Fu, Aung Naing, Filip Janku, Mingxuan Xu, Anas Alshawa, Nazanin Majd, Steven G Waguespack, Marta Penas-Prado, Carlos Kamiya-Matsuoka, Shaan M Raza, Ian E McCutcheon

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma

    Predictive Significance of Combined Plasmatic Detection of BRAF Mutations and S100B Tumor Marker in Early‐Stage Malignant Melanoma by Jiri Polivka, Mohamed A. Gouda, Mahyar Sharif, Martin Pesta, Helen Huang, Inka Treskova, Vlastimil Woznica, Jindra Windrichova, Katerina Houfkova, Radek Kucera, Tomas Fikrle, Jan Ricar, Kristyna Pivovarcikova, Ondrej Topolcan, Filip Janku

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma

    A Phase IB Trial of Selinexor in Combination With Immune Checkpoint Blockade in Patients With Advanced Renal Cell Carcinoma by Omar Alhalabi, Mohamed A. Gouda, Denái R. Milton, Hassan Ahmed Momin, Bulent Yilmaz, Bettzy Stephen, Chinenye Lynette Ejezie, Justin Tyler Moyers, Serdar A. Gurses, Jeffrey How, Siqing Fu, Jordi Rodon, David S. Hong, Sarina A. Piha‐Paul, Vivek Subbiah, Ecaterina Elena Dumbrava, Daniel D. Karp, Filip Janku, Funda Meric‐Bernstam, Nizar M. Tannir, Aung Naing

    Published 2025-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: